Status:
COMPLETED
Phenotyping Diabetic Retinopathy
Lead Sponsor:
Association for Innovation and Biomedical Research on Light and Image
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to validate and characterize phenotypes of diabetic retinopathy (DR) progression based on available clinical data (demographic, systemic and ophthalmic data).
Detailed Description
This study aims to validate and characterize phenotypes of diabetic retinopathy (DR) progression using ophthalmic and systemic data from type-2 diabetic subjects followed at the AIBILI Clinical Trial ...
Eligibility Criteria
Inclusion
- Diagnosis of DR.
- Females or Males;
- Age over 18 years;
- Signed Informed Consent;
- Previous follow-up with regular systemic and ophthalmic assessments.
Exclusion
- Cataract or other eye disease that may interfere with fundus examinations;
- Vitreous syneresis or posterior vitreous detachment;
- Dilatation of the pupil \< 5 mm.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00840541
Start Date
January 1 2009
End Date
January 1 2012
Last Update
April 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIBILI - Clinical Trial Center
Coimbra, Coimbra District, Portugal, 3000-548